PMBS Stock | News | Quote | Stock Forum | Tuesday, January 7,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
$PMBS PuraMed BioScience, Inc. PMBS Company Overview 

PuraMed BioScience, Inc. PMBS Current Price and Quotes
Last Price 0.0021
Previous Close 0.0018 Open 0.0018
Daily Range 0.0025 - 0.0017 52wk Range 0.015 - 0.0012
Volume 13,060,460 Dividend N/A
Average Vol (3m) 4,005,464 Yield N/A

PMBS Stock Message Board http://investorshangout.com/search?q=PMBS&...mp;yt1=Go!

Last Updated: Tuesday, January 7, 2014 01:22:20 AM

PuraMed BioScience, Inc. PMBS
Company Information

1326 Schofield Avenue
Schofield, WI 54476

Phone: 715-359-6373

PuraMed BioScience, Inc. PMBS
PuraMed BioScience, Inc. PMBS
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Sep 30, 2013 10-Q
CIK 0001409565
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o Dec 31, 2007
Incorporated In: MN, USA
Year of Inc. 2006
Employees Not Available
Company Officers/Contacts

Russell W. Mitchell CEO, Interim CFO
James W. Higgins COO
Company Directors

Russell W. Mitchell Chairman
Service Providers

Auditor/Accountant
Tanner LLC
215 South State St.
Suite 800
Salt Lake City, UT, 84111
United States

Legal Counsel
Lucosky Brookman LLP
33 Wood Avenue South
Woodbridge, NJ, 08830
United States

Investor Relations Firm
Not Available

PuraMed BioScience, Inc. PMBS
PMBS Security Details

Share Structure

Market Value1 $272,757 a/o Jan 06, 2014
Shares Outstanding 129,884,289 a/o Dec 31, 2013
Float Not Available
Authorized Shares 1,000,000,000 a/o Sep 30, 2013
Par Value  0.001
Shareholders

Shareholders of Record 317 a/o Oct 15, 2013
Short Selling Data

Short Interest 0 (-100%)
Dec 13, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

Interwest Transfer Co., Inc.

PuraMed BioScience, Inc. PMBS Financials
Period Ending Jun 30, 2013 Jun 30, 2012 Jun 30, 2011 Jun 30, 2010
Total Revenue 43 693 9 32
Cost of Revenue 95 184 7 14
Gross Profit (53) 509 1 18
Operating Expenses

Research and Development 75 18 59 109
Sales, General and Admin. 1,823 1,789 981 1,162
Non-Recurring Items - - - -
Other 55 51 49 49
Operating Income (2,006) (1,349) (1,087) (1,302)
Income From Continuing Operations

Add'l Income/Expense Items (28) 103 (77) -
Earnings Before Interest and Tax (2,034) (1,246) (1,164) (1,301)
Interest Expense 529 476 325 180
Earnings Before Tax (2,563) (1,721) (1,489) (1,481)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (2,657) (1,721) (1,489) (1,481)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (2,563) (1,721) (1,489) (1,481)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (2,563) (1,721) (1,489) (1,481)

PuraMed BioScience, Inc. PMBS Recent News

Nov 29, 2013 LipiGesic M stands alone among over-the-counter migraine medications based on recently released American Headache Society recommendations


PMBS PuraMed BioScience, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=PMBS&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/PMBS/quote
Stock Chart http://www.otcmarkets.com/stock/PMBS/chart
Company Info http://www.otcmarkets.com/stock/PMBS/company-info
Recent News http://www.otcmarkets.com/stock/PMBS/news
Financials http://www.otcmarkets.com/stock/PMBS/financials
Filings and Disclosure http://www.otcmarkets.com/stock/PMBS/filings
Short Sales http://www.otcmarkets.com/stock/PMBS/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/PMBS/insider-transactions
Research Reports http://www.otcmarkets.com/stock/PMBS/research
Summary http://finance.yahoo.com/q?s=PMBS
Historical Prices http://finance.yahoo.com/q/hp?s=PMBS+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=PMBS
Basic Chart http://finance.yahoo.com/q/bc?s=PMBS+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=PMBS+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=PMBS+Headlines
Press Releases http://finance.yahoo.com/q/p?s=PMBS+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=PMBS+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=PMBS+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=PMBS+Industry
Major Holders http://finance.yahoo.com/q/mh?s=PMBS+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=PMBS+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=PMBS+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=PMBS
Balance Sheet http://finance.yahoo.com/q/bs?s=PMBS
Cash Flow http://finance.yahoo.com/q/cf?s=PMBS+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/PMBS
Market Watch http://www.marketwatch.com/investing/stock/PMBS
Bloomberg http://www.bloomberg.com/quote/PMBS:US
Morningstar http://quotes.morningstar.com/stock/s?t=PMBS
Bussinessweek http://investing.businessweek.com/research/st...icker=PMBS
Barchart http://www.barchart.com/quotes/stocks/PMBS
OTC Short Report http://otcshortreport.com/index.php?index=PMBS
Investopedia http://www.investopedia.com/markets/stocks/PMBS/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Lauletta Birnbaum Earns Distinction in 2026 Chambers Guide

Updated Category News Views 209

Lauletta Birnbaum Recognized in the 2026 Chambers Spotlight Guide Lauletta Birnbaum has received prestigious recognition in the 2026 Chambers Spotlight Guide in the category of Corporate/Commercial Law. This honor highlights the firm's commitment to providing exceptional legal services to its clients. The Importance of Legal Recognition Chambers and Partners is recognized...

Continue Reading
Medicenna Therapeutics Showcases Advances in Cancer Treatment

Updated Category News Views 127

Medicenna Therapeutics Showcases Advances in Cancer Treatment Medicenna Therapeutics Corp. is making notable strides in the field of cancer immunotherapy. With a focus on developing innovative therapies, the company is gaining attention for its promising Superkines targeting a range of conditions, including cancer. One of their leading programs, MDNA11, has showcased...

Continue Reading
DÉKUPLE Reports Strong Growth in First-Half Earnings 2024

Updated Category News Views 258

DÉKUPLE reported its first-half earnings for 2024, showcasing an 8.8% rise in net sales, totaling €104.6 million. The figures signal a resilient company navigating a turbulent economic backdrop, but traders are already weighing the potential fallout. Key Financial Metrics: Profitability vs. Economic Headwinds The group's gross margin jumped 5.8%, hitting €83.5...

Continue Reading
Main Street Capital Corporation Declares 2025 Dividend Increases

Updated Category News Views 220

Regular Monthly Dividends Announced by Main Street Capital Main Street Capital Corporation (NYSE: MAIN) has taken a significant step forward in announcing its regular monthly dividends for the early part of 2025. The Board of Directors has declared a monthly dividend of $0.25 per share for January, February, and March of that year. This move showcases the company's...

Continue Reading
Exciting New Travel Offers Just for Travelzoo Club Members

Updated Category News Views 306

Exclusive Travel Offers for Club Members Travelzoo® (NASDAQ: TZOO), a leading platform for travel enthusiasts, has rolled out an enticing set of offers tailored specifically for its Club Members. These deals are meticulously negotiated to provide the best experiences at the most competitive prices. Whether you're looking for adventure or relaxation, there's something for...

Continue Reading